Nonviral gene delivery systems

Drug Profile

Nonviral gene delivery systems

Latest Information Update: 25 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Copernicus Therapeutics
  • Class DNA; Gene therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Retinitis pigmentosa; Unspecified

Most Recent Events

  • 25 Mar 2008 Preclinical development is ongoing
  • 11 Jun 2007 Preclinical data added to the Eye Disorders pharmacodynamics section
  • 02 Aug 2006 A preclinical study has been added to the Drug delivery systems pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top